Riskpilot← Back to searchSign inGet full accessIMMUDEX ApS
APSActiveCVR 31348854Bredevej 2AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200844 employeeswww.immudex.com
Revenue 2025
DKK 22,7M
-10% vs 2024
EBITDA margin
-39.7%
-14% vs 2024
Equity ratio
32.7%
Financial strength
Net profit 2025
DKK -11M
-55% vs 2024
| Revenue | DKK 22,7M | -10% |
| EBITDA | DKK -9M | -14% |
| Net profit | DKK -11M | -55% |
| Total assets | DKK 49,1M | +5% |
| Equity | DKK 16,1M | -36% |
| Employees | 44 | — |
Legal name
IMMUDEX ApS
CVR number
31348854
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. april 2008
Share capital
DKK 755.996
Employees
44 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsens formand eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er kommercialisering af immunmonitorerings metoder
Address
Bredevej 2A
Phone
+4531109191
Email
pd@immudex.com
Website
www.immudex.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -3.101 | 342 | 1.021 | 4.617 | 10.163 | 12.621 | 12.135 | 11.948 | 15.280 | 24.389 | 18.938 | 29.872 | 25.173 | 22.665 |
| Staff expenses | -9.439 | -7.177 | -6.310 | -6.408 | -6.551 | -8.194 | -9.625 | -14.048 | -17.002 | -22.616 | -27.971 | -29.836 | -33.091 | -31.671 |
| EBITDA | -12.540 | -6.835 | -5.290 | -1.791 | 3.612 | 4.427 | 2.510 | -2.099 | -1.723 | 1.774 | -9.034 | 36 | -7.918 | -9.006 |
| Depreciation & amort. | -123 | -150 | -133 | -90 | -52 | -48 | -192 | -306 | -537 | -1.076 | -1.476 | -1.525 | -1.694 | -1.982 |
| EBIT | -12.663 | -6.985 | -5.423 | -1.881 | 3.560 | 4.379 | 2.318 | -2.405 | -2.260 | 698 | -10.509 | -1.489 | -9.612 | -10.988 |
| Net financials | -2.284 | -3.098 | -3.464 | -4.115 | -4.660 | -4.457 | -1.045 | -92 | -159 | -548 | 2.540 | -708 | 514 | -2.148 |
| Profit before tax | -14.947 | -10.083 | -8.887 | -5.996 | -1.100 | -78 | 1.273 | -2.497 | -2.204 | 49 | -9.187 | -1.368 | -9.098 | -13.136 |
| Tax | -0 | -2.500 | -1.726 | -163 | -0 | -3.946 | 50 | -413 | -532 | -706 | -2.418 | -276 | -1.992 | -2.110 |
| Net profit | -14.947 | -7.583 | -7.161 | -5.833 | -1.100 | 3.868 | 1.224 | -2.084 | -1.671 | 754 | -6.769 | -1.092 | -7.106 | -11.025 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.106 | 7.979 | 7.719 | 11.382 | 11.786 | 26.207 | 29.018 | 28.424 | 45.963 | 46.841 | 41.060 | 42.449 | 46.587 | 49.096 |
| Equity | 5.447 | -2.136 | -6.640 | -4.673 | 1.464 | 13.713 | 14.937 | 12.853 | 33.697 | 34.451 | 29.376 | 29.924 | 24.947 | 16.050 |
| Long-term debt | 0 | 8.635 | 0 | 0 | 0 | 0 | 0 | 0 | 3.250 | 4.624 | 4.433 | 4.360 | 4.049 | 3.811 |
| Short-term debt | 1.659 | 1.481 | 14.359 | 16.055 | 10.322 | 12.494 | 14.082 | 15.571 | 9.016 | 7.766 | 7.251 | 8.165 | 17.591 | 29.235 |
| Total debt | 1.659 | 10.115 | 14.359 | 16.055 | 10.322 | 12.494 | 14.082 | 15.571 | 12.266 | 12.389 | 11.685 | 12.525 | 21.640 | 33.046 |
EBITDA margin
-39.7%
This company
15.8%
Market median
-351% vs market
20122025
Equity ratio
32.7%
This company
38.2%
Market median
+14% vs market
20122025
Return on equity
-68.7%
This company
18.4%
Market median
-473% vs market
20122025
Net profit margin
-48.6%
This company
8.1%
Market median
-700% vs market
20122025
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20122025
Debt / equity
2.06×
This company
0.62×
Market median
-232% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HK Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
HP Management | Management | 2008 | — | — |
PO Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2009 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2008 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2008 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
VIGGO HARBOE 2006 HOLDING ApS | Company | 50.0% | 50.0% | 2017 |
GUNNERSEN MARKER HOLDING ApS | Company | 20.0% | 20.0% | 2020 |
HJECA HOLDING I ApS | Company | 5.0% | 5.0% | 2017 |
CHEMGENE ApS | Company | 10.0% | 10.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Karmo Holding ApS
IMMUDEX ApS Board members of IMMUDEX ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helene Kähler Hjenner | Chief Executive Officer | 0 companies |
| Henrik Pedersen | Management | 0 companies |
| Patrik Olof Dahlén | Chief Executive Officer | 0 companies |
| Jørgen Axel Thorball | Chairman | 0 companies |
| Jørgen Schøller | Board of Directors | 0 companies |
| Henrik Pedersen | Chairman | 0 companies |
| Andrew David Gardiner | Board of Directors | 0 companies |
| Jamil El-Ali | Board of Directors | 0 companies |
| Douglas Frank Sweet | Board of Directors | 0 companies |
| Peter Andreas Stakemann | Chairman | 0 companies |
| Hans Christian Barré Pedersen | Board of Directors | 0 companies |
| Poul Valentin Hansen | Board of Directors | 0 companies |
| Søren Elmann Ingerslev | Chairman | 0 companies |